Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Platelet-rich plasma is beneficial in various plastic surgery applications, but more research is needed to standardize its use.

Lithium therapy may cause temporary hair loss, with possible regrowth if treatment is stopped or continued.

Erdr1 could be a new marker for diagnosing hair loss.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Narrowband-UVB phototherapy successfully treated a rare case of Graham Little-Piccardi-Lassueur syndrome.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Trichoscopy is useful for quickly diagnosing different types of hair loss without needing biopsies.

A gel made with finasteride, garlic oil, and Aloe vera using nanotechnology can potentially treat hair loss more effectively.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Some drugs used to treat immune conditions may cause different types of hair loss.

Phototherapy is effective and well-tolerated for treating childhood psoriasis and pityriasis lichenoides chronica.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Androgens may block hair growth signals, targeting this could treat hair loss.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Nickel, cobalt, balsam of Peru, fragrance mix, carba mix, and propylene glycol are common allergens causing scalp contact dermatitis.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Stopping the use of fluocinolone oil containing balsam fragrance improved hair regrowth in children allergic to it.

A 4-year-old girl was diagnosed with trichotillomania, a condition where she pulls out her hair, which may resolve on its own or require therapy.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib may effectively regrow hair in alopecia totalis patients.